Sanofi S.A., FR0000120578

Sanofi reports third-quarter results October 30: Sanofi stock sits 20.64 percent below high

Published on 10/13/2026 at 13:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sanofi has EUR 86.8 billion in market value. Sanofi stock costs EUR 72.34 on October 13, 2026, up 1.03 percent versus the Euronext Paris close.

Sanofi's investor calendar sets third-quarter results for October 30, 2026.
The company has EUR 86.8 billion in market value and a 22.32 price-to-earnings ratio.
Sanofi stock costs EUR 72.34 at Lang & Schwarz on October 13, 2026 at 1:07 p.m. CEST, up 1.03 percent versus the Euronext Paris close of October 12, 2026.
Sanofi's trailing dividend yield is 0.12 percent, while the 52-week range is EUR 69.75 to EUR 91.15.

Bold pop-art comic illustration of a gloved hand holding a glowing cyan syringe with radial energy lines on a violet halftone dot background — Sanofi FR0000120578 bold pop-art comic illustration of gloved hand holding glowing syringe with violet-cyan energy, Illustration mit AI erstellt.

Sanofi (ISIN FR0000120578) has its next major reporting date set for October 30, 2026, when it will publish third-quarter results. The date appears on Sanofi's investor-relations calendar. At Lang & Schwarz, Sanofi was trading at EUR 72.34 on October 13, 2026 at 1:07 p.m. CEST, up 1.03 percent versus the Euronext Paris close of October 12, 2026 at EUR 71.60.

Results date sets the next checkpoint

The October 30 release gives investors a defined date for the next test of Sanofi's operating performance. The investor presentation and question-and-answer session are scheduled for 1:30 p.m. CET, according to the company's calendar dated October 13, 2026.

The timing matters because Sanofi's shares are trading 20.64 percent below the EUR 91.15 52-week high and only 3.71 percent above the EUR 69.75 52-week low. That placement leaves the upcoming report as a measurable event for the stock rather than a distant calendar entry.

Valuation remains visible in the price

Sanofi's market capitalization was EUR 86.8 billion on October 13, 2026. The price-to-earnings ratio was 22.32, while the trailing dividend yield was 0.12 percent. The stock's 52-week range runs from EUR 69.75 to EUR 91.15, giving the current quotation a broad valuation frame without mixing currencies or venues.

Sanofi is a member of the CAC 40 and trades primarily on Euronext Paris under ticker SAN. The home-market quotation stood at EUR 72.29 at 12:54 p.m. CEST on October 13, 2026, according to the latest exchange-session data, while the Lang & Schwarz price was EUR 72.34 at 1:07 p.m. CEST.

Comparison with peers

Sanofi (Euronext Paris, EUR): plus 1.03 percent, P/E 22.32, market capitalization EUR 86.8 billion
GSK (London Stock Exchange, GBp): plus 0.79 percent, P/E 15.00
AstraZeneca (London Stock Exchange, GBp): plus 1.68 percent, P/E 24.25

Price stays above the yearly low

The current Sanofi quotation is EUR 2.59 above the Euronext Paris close of October 12, 2026, a 1.03 percent increase. The gain places the stock well above its yearly low but leaves it below the upper end of its range, with the October 30 results date now the next scheduled market checkpoint.

The further course of trading is shown by the continuously updated real-time quote of Sanofi stock.